About Cerebrum DAO
Cerebrum DAO is a company based in Zurich (Switzerland) founded in 2023. It operates as a D2C. Cerebrum DAO offers products and services including NEURON Token. Cerebrum DAO operates in a competitive market with competitors including Symbid, yeswetrust, Inoverte, Finovio and FIAG, among others.
- Headquarter Zurich, Switzerland
- SectorsHealthcare
- Website cerebrumdao.com
- Social LinkedIn X
Products & Services of Cerebrum DAO
Cerebrum DAO offers a comprehensive portfolio of products and services, including NEURON Token.
Token for participating in DAO governance and funding brain health research
People of Cerebrum DAO
2 people are tracked at Cerebrum DAO (2 in team).
| Name | Role | Group |
|---|---|---|
Mario B. | Collaborator | Team |
Brian Magierski | Founding Steward | Team |
Complete people profiles for Cerebrum DAO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Cerebrum DAO
Cerebrum DAO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Symbid, yeswetrust, Inoverte, Finovio and FIAG, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| symbid.com | 2011 | Rotterdam, Netherlands | – | – | Equity-based Crowdfunding | |
| yeswetrust.com | 2018 | Baar, Switzerland | – | – | An app-based platform is operated for crowdfunding multiple projects. | |
| inoverte.com | 2020 | St Gallen, Switzerland | – | – | Renewable energy projects for communities are financed via crowd-investing. | |
| finovio.com | 2019 | Zurich, Switzerland | – | – | A versatile platform for equity crowdfunding targeted at startups. | |
| fiag.group | 2021 | Baar, Switzerland | – | – | Provides startup financing, franchise advice, and investor connections for businesses. | |
| oomnium.com | 2019 | Zurich, Switzerland | – | – | Offers a platform for digital investment in startups, SMEs, and large companies. | |
| tcfx.io | 2023 | Neuchatel, Switzerland | – | – | Crowdfunding platform leveraging tokenization and blockchain for secure investments and capital raising. |
Detailed competitors of Cerebrum DAO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cerebrum Dao
Complete news archive for Cerebrum DAO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cerebrum DAO
10 companies that operate in the same segment as Cerebrum DAO (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cerebrum DAO
Cerebrum DAO was founded in 2023.
Cerebrum DAO is headquartered in Zurich, Switzerland.
Cerebrum DAO is an open global community that collectively sources and nurtures solutions for brain health, focusing on preventing neurodegeneration like Alzheimers. It operates through decentralized collaboration, funding translational research in neuroscience, and token-based governance. Members include researchers and supporters who vote on proposals and contribute skills. No specific location is mentioned, emphasizing a worldwide network.
Cerebrum DAO's top competitors include Symbid, yeswetrust and Inoverte.
Cerebrum DAO offers NEURON Token.